Iiizumi, S.; Ohtake, J.; Murakami, N.; Kouro, T.; Kawahara, M.; Isoda, F.; Hamana, H.; Kishi, H.; Nakamura, N.; Sasada, T.
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations. Cancers 2019, 11, 266.
https://doi.org/10.3390/cancers11020266
AMA Style
Iiizumi S, Ohtake J, Murakami N, Kouro T, Kawahara M, Isoda F, Hamana H, Kishi H, Nakamura N, Sasada T.
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations. Cancers. 2019; 11(2):266.
https://doi.org/10.3390/cancers11020266
Chicago/Turabian Style
Iiizumi, Susumu, Junya Ohtake, Naoko Murakami, Taku Kouro, Mamoru Kawahara, Fumiko Isoda, Hiroshi Hamana, Hiroyuki Kishi, Norihiro Nakamura, and Tetsuro Sasada.
2019. "Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations" Cancers 11, no. 2: 266.
https://doi.org/10.3390/cancers11020266
APA Style
Iiizumi, S., Ohtake, J., Murakami, N., Kouro, T., Kawahara, M., Isoda, F., Hamana, H., Kishi, H., Nakamura, N., & Sasada, T.
(2019). Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations. Cancers, 11(2), 266.
https://doi.org/10.3390/cancers11020266